1989
DOI: 10.1016/s0022-3476(89)80155-6
|View full text |Cite
|
Sign up to set email alerts
|

Regional cerebral blood flow velocity after aminophylline therapy in premature newborn infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
1

Year Published

1991
1991
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 16 publications
0
8
1
Order By: Relevance
“…These results apparently differ from previously studies that found that aminophylline [4,[6][7][8][9] and theophylline [5] significantly reduce CBF [5,[7][8][9] and CBF velocity [4,6]. Nonetheless, the study design of these papers is very different from ours: (1) loading doses of aminophylline (or theophylline) were administered to the patients; (2) some studies evaluated CBF [5,[7][8][9] and others evaluated CBF velocity [4,6]; (3) some studies were performed by cerebral Doppler ultrasounds [4,6], others by xenon clearance technique [5,7], or by NIRS [8,9]; (4) none of them provided continuous monitoring of cerebral hemodynamics that was able to show transient and slight changes, and (5) there is wide variability in the study period. In particular, Bucher et al [9] applied NIRS from 10 min before to 20 min after administration of aminophylline, while in the remaining studies data collection started 60 min after drug administration or later, and none of them investigated possible changes during this initial unrecorded period.…”
Section: Discussioncontrasting
confidence: 99%
“…These results apparently differ from previously studies that found that aminophylline [4,[6][7][8][9] and theophylline [5] significantly reduce CBF [5,[7][8][9] and CBF velocity [4,6]. Nonetheless, the study design of these papers is very different from ours: (1) loading doses of aminophylline (or theophylline) were administered to the patients; (2) some studies evaluated CBF [5,[7][8][9] and others evaluated CBF velocity [4,6]; (3) some studies were performed by cerebral Doppler ultrasounds [4,6], others by xenon clearance technique [5,7], or by NIRS [8,9]; (4) none of them provided continuous monitoring of cerebral hemodynamics that was able to show transient and slight changes, and (5) there is wide variability in the study period. In particular, Bucher et al [9] applied NIRS from 10 min before to 20 min after administration of aminophylline, while in the remaining studies data collection started 60 min after drug administration or later, and none of them investigated possible changes during this initial unrecorded period.…”
Section: Discussioncontrasting
confidence: 99%
“…Rosenkrantz and Oh observed a 21% reduction of cerebral blood flow velocity after intravenous aminophylline, but this reduction may partly have been caused by the concomitant decrease of PaCO2 [14]. In other studies, the cerebral blood flow velocity seemed to be unaffected by aminophylline or caffeine [2,9,15,17]. The failure of demonstrating a reduction in CBF, however, may be because these investigators did not take the intra-individual changes in PaCO2 into account.…”
Section: Discussionmentioning
confidence: 92%
“…Several studies have demonstrated an increase in heart rate of 8-20 bpm 1-48 h after a loading dose of 4-6 mg/kg body weight [12,21]. This increase is dose dependent [19].…”
Section: Discussionmentioning
confidence: 98%